Lipidomics Investigation Reveals the Reversibility of Hepatic Injury by Silica Nanoparticles in Rats After a 6‐Week Recovery Duration
Small Methods · 2024
DOI: 10.1002/smtd.202301430 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small Methods, 2024. Verfasst von Xinying Zhao und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, 100069, China. Hauptthemen laut MEDLINE: Silicon Dioxide, Lipidomics, Nanoparticles, Chemical and Drug Induced Liver Injury. Die Arbeit nennt 102 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Special Funds for the Construction of High-level Public Health Technical Talents.
Abstract (Originalsprache)
Given the inevitable human exposure owing to its increasing production and utilization, the comprehensive safety evaluation of silica nanoparticles (SiNPs) has sparked concerns. Substantial evidence indicated liver damage by inhaled SiNPs. Notwithstanding, few reports focused on the persistence or reversibility of hepatic injuries, and the intricate molecular mechanisms involved remain limited. Here, rats are intratracheally instilled with SiNPs in two regimens (a 3‐month exposure and a subsequent 6‐week recovery after terminating SiNPs administration) to assess the hepatic effects. Nontargeted lipidomics revealed alterations in lipid metabolites as a contributor to the hepatic response and recovery effects of SiNPs. In line with the functional analysis of differential lipid metabolites, SiNPs activated oxidative stress, and induced lipid peroxidation and lipid deposition in the liver, as evidenced by the elevated hepatic levels of ROS, MDA, TC, and TG. Of note, these indicators showed great improvements after a 6‐week recovery, even returning to the control levels. According to the correlation, ROC curve, and SEM analysis, 11 lipids identified as potential regulatory molecules for ameliorating liver injury by SiNPs. Collectively, the work first revealed the reversibility of SiNP‐elicited hepatotoxicity from the perspective of lipidomics and offered valuable laboratory evidence and therapeutic strategy to facilitate nanosafety.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Toxicology and Sanitary Chemistry, School of Public Health, Capital Medical University, Beijing, 100069, China.
- Beijing Key Laboratory of Environmental Toxicology, Capital Medical University, Beijing, 100069, China.
- Department of Occupational Health and Environmental Health, School of Public Health, Capital Medical University, Beijing, 100069, China.
- School of Public Health, Shenzhen University Medical School, Shenzhen University, Shenzhen, 518060, China.
- Department of Nephrology, Affiliated Beijing Chaoyang Hospital of Capital Medical University, Beijing, 100020, China.
ORCID-Profile: Yanbo Li
Förderung
- National Natural Science Foundation of China
- Special Funds for the Construction of High-level Public Health Technical Talents
Zitieren
APA
Zhao, X., Zhu, Y., Yao, Q., Zhao, B., Lin, G., Zhang, M., Guo, C., & Li, Y. (2024). Lipidomics Investigation Reveals the Reversibility of Hepatic Injury by Silica Nanoparticles in Rats After a 6‐Week Recovery Duration. Small Methods. https://doi.org/10.1002/smtd.202301430
Vancouver
Zhao X, Zhu Y, Yao Q, Zhao B, Lin G, Zhang M, et al. Lipidomics Investigation Reveals the Reversibility of Hepatic Injury by Silica Nanoparticles in Rats After a 6‐Week Recovery Duration. Small Methods. 2024. doi:10.1002/smtd.202301430
BibTeX
@article{Zhao2024,
author = {Zhao, Xinying and Zhu, Yawen and Yao, Qing and Zhao, Bosen and Lin, Guimiao and Zhang, Min and Guo, Caixia and Li, Yanbo},
title = {Lipidomics Investigation Reveals the Reversibility of Hepatic Injury by Silica Nanoparticles in Rats After a 6‐Week Recovery Duration},
journal = {Small Methods},
year = {2024},
doi = {10.1002/smtd.202301430}
}
EUVIMED